封面
市场调查报告书
商品编码
1181672

医药品物流的全球市场 - 预测与展望(2022年~2027年)

Pharmaceutical Logistics Market - Global Outlook & Forecast 2022-2027

出版日期: | 出版商: Arizton Advisory & Intelligence | 英文 367 Pages | 订单完成后即时交付

价格

全球医药品物流的市场规模在2022年~2027年预计将以年复合成长率7.96%的速度成长。增加监控和对安全冷链解决方案的需求是推动市场的一些因素。

本报告提供全球医药品物流市场相关调查分析,提供市场规模与预测,促进因素,竞争情形等资讯。

目录

第1章 调查手法

第2章 调查目的

第3章 调查流程

第4章 范围

第5章 报告的前提条件与注意事项

第6章 市场概要

第7章 简介

  • 背景
  • COVID-19对全球供应链的影响

第8章 主要考察

第9章 市场机会及趋势

第10章 促进市场的成长要素

第11章 阻碍市场要素

第12章 市场形势

  • 市场概要
  • 市场规模与预测
    • 考察:各治疗领域
    • 考察:各来历
    • 考察:各产品
    • 考察:各功能
    • 地区:各地区
  • 波特的五力分析

第13章 治疗领域

  • 市场概述与成长引擎
  • 市场概要
  • 传染病
  • 肿瘤
  • 糖尿病
  • 心血管疾病
  • 自体免疫疾病
  • 神经病变
  • 疼痛管理
  • 呼吸疾病
  • 其他

第14章 来历

  • 市场概述与成长引擎
  • 市场概要
  • 品牌医药品
  • 学名药
  • OTC

第15章 产品

  • 市场概述与成长引擎
  • 市场概要
  • 低分子医药品
  • 生技药品
  • 单株抗体
  • 疫苗
  • 其他

第16章 功能

  • 市场概述与成长引擎
  • 市场概要
  • 运输
  • 陆上
  • 水上
  • 航空
  • 保管
  • 其他

第17章 地区

  • 市场概述与成长引擎
  • 地理概要

第18章 北美

  • 市场概要
  • 市场规模与预测
  • 北美:各治疗领域
  • 北美:来历
  • 北美:各产品
  • 北美:各功能
  • 主要国家
    • 美国:市场规模与预测
    • 加拿大:市场规模与预测

第19章 欧洲

  • 市场概要
  • 市场规模与预测
  • 欧洲:各治疗领域
  • 欧洲:来历
  • 欧洲:各产品
  • 欧洲:各功能
  • 主要国家
    • 德国:市场规模与预测
    • 法国:市场规模与预测
    • 英国:市场规模与预测
    • 义大利:市场规模与预测
    • 西班牙:市场规模与预测

第20章 亚太地区

  • 市场概要
  • 市场规模与预测
  • 亚太地区:各治疗领域
  • 亚太地区:来历
  • 亚太地区:各产品
  • 亚太地区:各功能
  • 主要国家
    • 中国:市场规模与预测
    • 日本:市场规模与预测
    • 印度:市场规模与预测
    • 韩国:市场规模与预测
    • 澳洲:市场规模与预测

第21章 南美

  • 市场概要
  • 市场规模与预测
  • 南美:各治疗领域
  • 南美:来历
  • 南美:各产品
  • 南美:各功能
  • 主要国家
    • 巴西:市场规模与预测
    • 墨西哥:市场规模与预测
    • 阿根廷:市场规模与预测

第22章 中东·非洲

  • 市场概要
  • 市场规模与预测
  • 中东·非洲:各治疗领域
  • 中东·非洲:来历
  • 中东·非洲:各产品
  • 中东·非洲:各功能
  • 主要国家
    • 土耳其:市场规模与预测
    • 沙乌地阿拉伯:市场规模与预测
    • 南非:市场规模与预测

第23章 竞争情形

  • 竞争概要
    • AMERISOURCEBERGEN
    • DB GROUP
    • DEUTSCHE POST DHL
    • CEVA LOGISTICS
    • UNITED PARCEL SERVICE
    • FEDEX
    • KUEHNE+NAGEL

第24章 主要企业简介

  • AMERISOURCEBERGEN
  • CEVA LOGISTICS
  • DB GROUP
  • DEUTSCHE POST DHL
  • FEDEX
  • KUEHNE+NAGEL
  • UNITED PARCEL SERVICE

第25章 其他的着名的供应商

  • ABS LOGISTICS
  • AWL INDIA
  • ALLOGA
  • BOLLORE LOGISTICS
  • CARDINAL HEALTH
  • C.H. ROBINSON
  • COLD CHAIN TECHNOLOGIES
  • CRYOPDP
  • DPD
  • DSV
  • FARMASOFT
  • JEENA & COMPANY
  • LUFTHANSA CARGO
  • A.P. MOLLER - MAERSK
  • MEDLINE
  • NIPPON EXPRESS
  • NOATUM LOGISTICS
  • OWENS & MINOR
  • OXIMIO
  • PHARMA LOGISTICS
  • PHOENIX GROUP
  • PAREXEL INTERNATIONAL
  • SEKO LOGISTICS
  • SINGAPORE POST
  • SINOTRANS
  • XPO LOGISTICS
  • YOURWAY
  • YUSEN LOGISTICS

第26章 报告摘要

  • 重要事项
  • 策略性推荐事项

第27章 定量性摘要

第28章 附录

Product Code: ARZ221106

The global pharmaceutical logistics market is expected to grow at a CAGR of 7.96% during 2022-2027.

MARKET OVERVIEW

Technological advancements are disrupting the logistics providers to improve the healthcare business model ecosystem, including pharmaceuticals. Further, increased usage of logistics optimization tools, AI, IoT, and intelligent logistics platforms are likely to contribute to the future growth of the pharmaceutical logistics market.

Pharmaceutical logistics deals with manufacturing, processing, shipping materials, and resources and activities related to handling manufactured goods by their customers. Logistics companies play a crucial role in the functioning of any pharmaceutical company. The growing adoption of water-based pharmaceutical logistics is one of the significant driving factors in the pharmaceutical logistics market. Pharmaceutical logistics showed a healthy growth rate even before the COVID-19 pandemic. The sector is undergoing several changes as the geriatric population drives the need for new pharma solutions. However, the COVID-19 pandemic has created complexities in the global supply chain that has impacted all the modes of freight transportation, from air to rail cargo, that may take months or years to get back to normal.

TRENDING FACTORS

Clinical research has recently become more globalized, with many of these studies being conducted globally and a significant increase in clinical trials in developing countries. The focus of clinical trial researchers is now shifting from developed markets of Japan, Australia, South Korea, and Singapore towards emerging economies like Thailand, China, the Philippines, and Vietnam.

Major companies are striving to offer cloud-based supply chain services and secured supply chain functions as it helps pharmaceutical manufacturers safeguard the validity of the drugs. These solutions are expected to prevent the production and distribution of counterfeit drugs. According to DB Schenker, a subsidiary of DB Group, to increase transport density and reliability, the shift to digital rail operations and digitalization of infrastructure and vehicles is essential in the pharmaceutical logistics market. Also, in 2019, TrakCel, one of the global leaders in managing clinical supply chain logistics, partnered with Quick Group to provide industry-leading digital supply chain IT solutions for cell and gene therapies. Also, the recent emergence of cell and gene therapy is expected to create lucrative opportunities for the pharmaceutical logistics market.

Driving Factors Of The Global Pharmaceutical Logistics Market:

  • Need for secure cold-chain solutions and increased monitoring
  • Evolving storage and transportation needs
  • Rising branded, generic, and OTC drugs

SEGMENTATION INSIGHTS

INSIGHTS BY THERAPY AREA

    • In therapy area segmentation, the communicable diseases segment dominated the global pharmaceutical logistics market with a share of 19.96% owing to the emergence of the COVID-19 pandemic that upsurged the communicable disease cases. According to the latest European Centre for Disease Prevention and Control (ECDC) report, tuberculosis remains one of the world's deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern that is made the communicable diseases dominant in the last few years. In 2019, communicable diseases ranked third with the highest number of cases, while the emergence of the COVID-19 pandemic dominated the segment in 2021. The upsurge in COVID-19 cases contributed to the highest share of communicable diseases, leading to increased demand for OTC medicines and vaccines.
    • The oncology segment accounted for the second-largest segment in the pharmaceutical logistics market with a revenue share of 15.17%, owing to growing cancer prevalence and demand for anti-tumor agents. It is also expected to grow at the highest CAGR of 14.02%. The current pharmaceuticals pipeline is disproportionately focused on cancer.
    • The world is expecting more pandemics in the future, particularly with monkeypox spreading in more than 60 countries which are expected to drive the demand for new medications and more clinical trials, thus boosting the demand for logistics during clinical trials and distributing products.

Segmentation by Therapy Area

  • Communicable Diseases
  • Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Neurological Disorders
  • Pain Management
  • Respiratory Diseases
  • Others

INSIGHTS BY ORIGIN

    • Under origin segmentation, branded drugs accounted for the highest revenue share in the global pharmaceutical logistics market. This is mainly due to their high preference and the high cost of branded drugs, which makes up the high revenue share of pharmaceutical logistics for branded drugs. According to the Association for Accessible Medicines, US Generic & Biosimilar Medicines Savings Report and National Sales Perspectives, in December 2020, branded drugs spending was around 80% of the share from 2018-2020. However, the generic drugs segment is expected to grow at the highest CAGR of 72.25% during the forecast period.

Segmentation by Origin

  • Branded
  • Generic
  • OTC

INSIGHTS BY PRODUCT

    • Under product segmentation, small molecule drugs dominate the global pharmaceutical logistics market with a revenue share of 63.02% in 2021 due to increasing demand and its cost-effectiveness, ease of administration, and easy dosing. The demand for small-molecule drugs remains high, with figures showing that 97% of marketed drugs are classified as small molecules. However, biologics lead among the top-selling products and new sales generators projected for 2022, whereas small molecules continue to lead in new drug approvals. According to US FDA's Center for Drug Evaluation and Research, of the 50 new molecular entities approved by the US FDA's Center for Drug Evaluation and Research in 2021, 36 (72%) were small molecules, and 14(28%) were biologics.

Segmentation by Product

  • Small Molecule Drugs
  • Biologics

INSIGHTS BY FUNCTION

    • As transportation is a crucial part of the logistics chain, thus it accounts for the highest revenue share of 71.66% in the pharmaceutical logistics market in 2021 and continues to grow with the highest CAGR of 8.20% during the forecast period. The demand for temperature-controlled transportation is also rising to maintain the quality of the products. Road transportation dominates the transportation segment with a revenue share of 66.38% in 2021, whereas the water and air transportation segments accounted for 21.21% and 12.41%, respectively, in the same year. The highest share of road transportation can be attributed to its low cost in terms of workforce and operation. In January 2021, more than 58% of US-Canada cross-border freight was moved by trucks, followed by rail with more than 16% of cross-border freight.
    • However, in 2020, European land transport declined because of the COVID-19 pandemic. Between April and August 2020, after decreased prices and falling demand, prices grew exponentially to the previous year's level from October 2020, and the demand increased significantly. As the air rates are higher than water and road, thus the demand for logistics via air is lowest.
    • Air freight is 78% more expensive than ocean freight, leading the pack with 80% of all temperature excursions for pharmaceutical products transportation. In comparison, ocean transportation has a mere 1% temperature excursion rate, while road transport is a little higher, with 18% of all the excursions. There is still a lot of work for the air cargo supply chain to come up to speed for the growing global trade in pharmaceutical products. Despite that, the global pharmaceutical logistics market by air is growing at the fastest CAGR of 9.16% during the forecast period.

Segmentation by Function

  • Transportation
  • Warehousing
  • Others

GEOGRAPHY INSIGHTS

  • North America region accounts for the highest revenue share of 38.70% in the global pharmaceutical logistics market in 2021 and holds the presence of most pharmaceutical suppliers. The US is the leading country worldwide with the highest share of pharmaceuticals. About five of the ten top pharmaceutical companies in 2020 were from the US. In the US, branded drugs accounted for around 83.9% of spending. In 2020, about 8.1% of worldwide drug and medicine shipments originated from North America.
  • North America and Europe have accounted for about 80% of monoclonal antibodies market share alone; thus, the growing demand for biologics, i.e., vaccines and monoclonal antibodies, and increasing investments in R&D are the major driving factors for the pharmaceutical logistics market. Europe is the number one exporter of pharmaceutical drugs. The pharmaceutical logistics demand in Europe is driven by the growing demand for biologics such as vaccines, propelled by the COVID-19 pandemic and growing investments by leading pharmaceutical firms. In 2019, pharmaceutical industry sales in the country increased by 5.7%, reaching about USD 52.1 billion. More than 500 pharmaceutical companies are in Germany. Small and mid-size enterprises (SMEs) constitute the backbone of the economic sector, with around 90% of drug manufacturers. In 2018, Germany generated a production value of USD 42.1 billion, making it the leading pharmaceutical manufacturing country in Europe.
  • The pharmaceutical logistics market in APAC was valued at USD 20.79 billion in 2021. Asia Pacific is the largest manufacturing region and provider of generic drugs, vaccines, OTC drugs, biosimilars, custom research manufacturing, and active pharmaceutical ingredients; many countries are importing pharmaceuticals from this region. Hence, the growing demand for these pharmaceutical products is the major driving factor for transportation and warehousing activities in the region. India has the highest share of about 20% of the global supply volume. Moreover, it contributes to around 60% of global vaccines. India majorly exports biologics, which contribute to about 75% of the total pharmaceutical exports out of India. In addition, Latin America, the Middle East & Africa, and the APAC region are the major emerging markets for pharmaceutical logistics market growth. Factors such as rapid population growth, steady increase in the elderly population, and increased prevalence of chronic, non-communicable diseases are the major driving factors in these regions for growth in the pharmaceutical logistics market.

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • Italy
    • Spain
    • France
    • UK
  • APAC
    • Japan
    • China
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

VENDOR LANDSCAPE

AmerisourceBergen, CEVA Logistics, Deutsch Post DHL, FedEx, Kuehne + Nagel, DB Schenker, and UPS are the key vendors in the pharmaceutical logistics market. These companies have a broad geographical footprint, a strong focus on innovation in logistics, and a diversified service portfolio. Upcoming new advanced technologies and increased demand for personalized medicines are providing lucrative opportunities for stakeholders to take the companies to the next level. Technologies such as data mining, mobile cloud, time analytics, and blockchain are expected to create better app interfaces and cloud infrastructure, which is expected to provide better growth opportunities in the post-pandemic pharmaceutical logistics market.

In addition to technological advances, companies invest in inorganic growth methods such as acquisitions. For instance, on June 2, 2021, the leading company, AmerisourceBergen, completed the acquisition of most of Walgreens Boots Alliance's Alliance Healthcare businesses for USD 6.27 billion cash which will help the company expand its reach and solutions in pharmaceutical distribution. Similarly, In August 2021, the leading company Deutsche Post DHL Group, signed an agreement to acquire 100% of J.F. Hillebrand Group and its subsidiaries.

Key Vendors

  • AmerisourceBergen
  • CEVA Logistics
  • DB Group
  • Deutsche Post DHL
  • FedEx
  • Kuehne + Nagel
  • United Parcel Service

Other Prominent Vendors

  • ABS Logistics
  • AWL India
  • Alloga
  • BOLLORE LOGISTICS
  • Cardinal Health
  • C.H. Robinson
  • Cold Chain Technologies
  • CRYOPDP
  • DPD
  • DSV
  • Farmasoft
  • Jeena & Company
  • Lufthansa Cargo
  • Maersk
  • Medline
  • Nippon Express
  • Noatum Logistics
  • Owens & Minor
  • Oximio
  • Pharma Logistics
  • PHOENIX Group
  • Parexel International
  • SEKO Logistics
  • Singapore Post
  • SINOTRANS
  • XPO Logistics
  • Yourway
  • YUSEN LOGISTICS

KEY QUESTIONS ANSWERED

  • 1. How big is the pharmaceutical logistics market?
  • 2. What is the pharmaceutical logistics market growth?
  • 3. What are the trends in the global pharmaceutical logistics market?
  • 4. Which region holds the largest pharmaceutical logistics market share globally?
  • 5. Which are the leading companies in the global pharmaceutical logistics market?
  • 6. What is the leading product in the pharmaceutical logistics market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY THERAPY AREA
    • 4.3.2 MARKET SEGMENTATION BY ORIGIN
    • 4.3.3 MARKET SEGMENTATION BY PRODUCT
    • 4.3.4 MARKET SEGMENTATION BY FUNCTION
    • 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

  • 7.1 BACKGROUND
  • 7.2 IMPACT OF COVID-19 ON GLOBAL SUPPLY CHAIN

8 PREMIUM INSIGHTS

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS
  • 9.2 DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS
  • 9.3 INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS

10 MARKET GROWTH ENABLERS

  • 10.1 INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES
  • 10.2 GROWING DEMAND FOR OCEAN FREIGHT SERVICE
  • 10.3 INCREASING DEMAND FOR GENERICS AND BIOSIMILARS

11 MARKET RESTRAINTS

  • 11.1 LACK OF COMPLIANCE AND CHANGING REGULATIONS
  • 11.2 IMPACT OF COVID-19 PANDEMIC
  • 11.3 GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 INSIGHTS BY THERAPY AREA
    • 12.2.2 INSIGHTS BY ORIGIN
    • 12.2.3 INSIGHTS BY PRODUCT
    • 12.2.4 INSIGHTS BY FUNCTION
    • 12.2.5 INSIGHTS BY GEOGRAPHY
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 THERAPY AREA

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 COMMUNICABLE DISEASES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 ONCOLOGY
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 DIABETES
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY
  • 13.6 CARDIOVASCULAR DISEASES
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 MARKET BY GEOGRAPHY
  • 13.7 AUTOIMMUNE DISEASES
    • 13.7.1 MARKET OVERVIEW
    • 13.7.2 MARKET SIZE & FORECAST
    • 13.7.3 MARKET BY GEOGRAPHY
  • 13.8 NEUROLOGICAL DISORDERS
    • 13.8.1 MARKET OVERVIEW
    • 13.8.2 MARKET SIZE & FORECAST
    • 13.8.3 MARKET BY GEOGRAPHY
  • 13.9 PAIN MANAGEMENT
    • 13.9.1 MARKET OVERVIEW
    • 13.9.2 MARKET SIZE & FORECAST
    • 13.9.3 MARKET BY GEOGRAPHY
  • 13.10 RESPIRATORY DISEASES
    • 13.10.1 MARKET OVERVIEW
    • 13.10.2 MARKET SIZE & FORECAST
    • 13.10.3 MARKET BY GEOGRAPHY
  • 13.11 OTHERS
    • 13.11.1 MARKET OVERVIEW
    • 13.11.2 MARKET SIZE & FORECAST
    • 13.11.3 MARKET BY GEOGRAPHY

14 ORIGIN

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 BRANDED DRUGS
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 GENERIC DRUGS
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 OTC
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY

15 PRODUCT

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 SMALL MOLECULE DRUGS
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 BIOLOGICS
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY
  • 15.5 MONOCLONAL ANTIBODIES
    • 15.5.1 MARKET OVERVIEW
    • 15.5.2 MARKET SIZE & FORECAST
  • 15.6 VACCINES
    • 15.6.1 MARKET OVERVIEW
    • 15.6.2 MARKET SIZE & FORECAST
  • 15.7 OTHERS
    • 15.7.1 MARKET OVERVIEW
    • 15.7.2 MARKET SIZE & FORECAST

16 FUNCTION

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 TRANSPORTATION
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
    • 16.3.3 MARKET BY GEOGRAPHY
  • 16.4 ROAD
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
  • 16.5 WATER
    • 16.5.1 MARKET OVERVIEW
    • 16.5.2 MARKET SIZE & FORECAST
  • 16.6 AIR
    • 16.6.1 MARKET OVERVIEW
    • 16.6.2 MARKET SIZE & FORECAST
  • 16.7 WAREHOUSING
    • 16.7.1 MARKET OVERVIEW
    • 16.7.2 MARKET SIZE & FORECAST
    • 16.7.3 MARKET BY GEOGRAPHY
  • 16.8 OTHERS
    • 16.8.1 MARKET OVERVIEW
    • 16.8.2 MARKET SIZE & FORECAST
    • 16.8.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

  • 17.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 NORTH AMERICA BY THERAPY AREA
  • 18.4 NORTH AMERICA BY ORIGIN
  • 18.5 NORTH AMERICA BY PRODUCT
  • 18.6 NORTH AMERICA BY FUNCTION
  • 18.7 KEY COUNTRIES
    • 18.7.1 US: MARKET SIZE & FORECAST
    • 18.7.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 EUROPE BY THERAPY AREA
  • 19.4 EUROPE BY ORIGIN
  • 19.5 EUROPE BY PRODUCT
  • 19.6 EUROPE BY FUNCTION
  • 19.7 KEY COUNTRIES
    • 19.7.1 GERMANY: MARKET SIZE & FORECAST
    • 19.7.2 FRANCE: MARKET SIZE & FORECAST
    • 19.7.3 UK: MARKET SIZE & FORECAST
    • 19.7.4 ITALY: MARKET SIZE & FORECAST
    • 19.7.5 SPAIN: MARKET SIZE & FORECAST

20 APAC

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 APAC BY THERAPY AREA
  • 20.4 APAC BY ORIGIN
  • 20.5 APAC BY PRODUCT
  • 20.6 APAC BY FUNCTION
  • 20.7 KEY COUNTRIES
    • 20.7.1 CHINA: MARKET SIZE & FORECAST
    • 20.7.2 JAPAN: MARKET SIZE & FORECAST
    • 20.7.3 INDIA: MARKET SIZE & FORECAST
    • 20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 20.7.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
  • 21.3 LATIN AMERICA BY THERAPY AREA
  • 21.4 LATIN AMERICA BY ORIGIN
  • 21.5 LATIN AMERICA BY PRODUCT
  • 21.6 LATIN AMERICA BY FUNCTION
  • 21.7 KEY COUNTRIES
    • 21.7.1 BRAZIL: MARKET SIZE & FORECAST
    • 21.7.2 MEXICO: MARKET SIZE & FORECAST
    • 21.7.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

  • 22.1 MARKET OVERVIEW
  • 22.2 MARKET SIZE & FORECAST
  • 22.3 MIDDLE EAST & AFRICA BY THERAPY AREA
  • 22.4 MIDDLE EAST & AFRICA BY ORIGIN
  • 22.5 MIDDLE EAST & AFRICA BY PRODUCT
  • 22.6 MIDDLE EAST & AFRICA BY FUNCTION
  • 22.7 KEY COUNTRIES
    • 22.7.1 TURKEY: MARKET SIZE & FORECAST
    • 22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

  • 23.1 COMPETITION OVERVIEW
    • 23.1.1 AMERISOURCEBERGEN
    • 23.1.2 DB GROUP
    • 23.1.3 DEUTSCHE POST DHL
    • 23.1.4 CEVA LOGISTICS
    • 23.1.5 UNITED PARCEL SERVICE
    • 23.1.6 FEDEX
    • 23.1.7 KUEHNE+NAGEL

24 KEY COMPANY PROFILES

  • 24.1 AMERISOURCEBERGEN
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 SERVICE OFFERINGS
    • 24.1.3 KEY STRATEGIES
    • 24.1.4 KEY STRENGTHS
    • 24.1.5 KEY OPPORTUNITIES
  • 24.2 CEVA LOGISTICS
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 SERVICE OFFERINGS
    • 24.2.3 KEY STRATEGIES
    • 24.2.4 KEY STRENGTHS
    • 24.2.5 KEY OPPORTUNITIES
  • 24.3 DB GROUP
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 SERVICE OFFERINGS
    • 24.3.3 KEY STRATEGIES
    • 24.3.4 KEY STRENGTHS
    • 24.3.5 KEY OPPORTUNITIES
  • 24.4 DEUTSCHE POST DHL
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 SERVICE OFFERINGS
    • 24.4.3 KEY STRATEGIES
    • 24.4.4 KEY STRENGTHS
    • 24.4.5 KEY OPPORTUNITIES
  • 24.5 FEDEX
    • 24.5.1 BUSINESS OVERVIEW
    • 24.5.2 SERVICE OFFERINGS
    • 24.5.3 KEY STRATEGIES
    • 24.5.4 KEY STRENGTHS
    • 24.5.5 KEY OPPORTUNITIES
  • 24.6 KUEHNE + NAGEL
    • 24.6.1 BUSINESS OVERVIEW
    • 24.6.2 SERVICE OFFERINGS
    • 24.6.3 KEY STRATEGIES
    • 24.6.4 KEY STRENGTHS
    • 24.6.5 KEY OPPORTUNITIES
  • 24.7 UNITED PARCEL SERVICE
    • 24.7.1 BUSINESS OVERVIEW
    • 24.7.2 SERVICE OFFERINGS
    • 24.7.3 KEY STRATEGIES
    • 24.7.4 KEY STRENGTHS
    • 24.7.5 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

  • 25.1 ABS LOGISTICS
    • 25.1.1 BUSINESS OVERVIEW
    • 25.1.2 SERVICE OFFERINGS
  • 25.2 AWL INDIA
    • 25.2.1 BUSINESS OVERVIEW
    • 25.2.2 SERVICE OFFERINGS
  • 25.3 ALLOGA
    • 25.3.1 BUSINESS OVERVIEW
    • 25.3.2 SERVICE OFFERINGS
  • 25.4 BOLLORE LOGISTICS
    • 25.4.1 BUSINESS OVERVIEW
    • 25.4.2 SERVICE OFFERINGS
  • 25.5 CARDINAL HEALTH
    • 25.5.1 BUSINESS OVERVIEW
    • 25.5.2 SERVICE OFFERINGS
  • 25.6 C.H. ROBINSON
    • 25.6.1 BUSINESS OVERVIEW
    • 25.6.2 SERVICE OFFERINGS
  • 25.7 COLD CHAIN TECHNOLOGIES
    • 25.7.1 BUSINESS OVERVIEW
    • 25.7.2 SERVICE OFFERINGS
  • 25.8 CRYOPDP
    • 25.8.1 BUSINESS OVERVIEW
    • 25.8.2 SERVICE OFFERINGS
  • 25.9 DPD
    • 25.9.1 BUSINESS OVERVIEW
    • 25.9.2 SERVICE OFFERINGS
  • 25.10 DSV
    • 25.10.1 BUSINESS OVERVIEW
    • 25.10.2 SERVICE OFFERINGS
  • 25.11 FARMASOFT
    • 25.11.1 BUSINESS OVERVIEW
    • 25.11.2 SERVICE OFFERINGS
  • 25.12 JEENA & COMPANY
    • 25.12.1 BUSINESS OVERVIEW
    • 25.12.2 SERVICE OFFERINGS
  • 25.13 LUFTHANSA CARGO
    • 25.13.1 BUSINESS OVERVIEW
    • 25.13.2 SERVICE OFFERINGS
  • 25.14 A.P. MOLLER - MAERSK
    • 25.14.1 BUSINESS OVERVIEW
    • 25.14.2 SERVICE OFFERINGS
  • 25.15 MEDLINE
    • 25.15.1 BUSINESS OVERVIEW
    • 25.15.2 SERVICE OFFERINGS
  • 25.16 NIPPON EXPRESS
    • 25.16.1 BUSINESS OVERVIEW
    • 25.16.2 SERVICE OFFERINGS
  • 25.17 NOATUM LOGISTICS
    • 25.17.1 BUSINESS OVERVIEW
    • 25.17.2 SERVICE OFFERINGS
  • 25.18 OWENS & MINOR
    • 25.18.1 BUSINESS OVERVIEW
    • 25.18.2 SERVICE OFFERINGS
  • 25.19 OXIMIO
    • 25.19.1 BUSINESS OVERVIEW
    • 25.19.2 SERVICE OFFERINGS
  • 25.20 PHARMA LOGISTICS
    • 25.20.1 BUSINESS OVERVIEW
    • 25.20.2 SERVICE OFFERINGS
  • 25.21 PHOENIX GROUP
    • 25.21.1 BUSINESS OVERVIEW
    • 25.21.2 SERVICE OFFERINGS
  • 25.22 PAREXEL INTERNATIONAL
    • 25.22.1 BUSINESS OVERVIEW
    • 25.22.2 SERVICE OFFERINGS
  • 25.23 SEKO LOGISTICS
    • 25.23.1 BUSINESS OVERVIEW
    • 25.23.2 SERVICE OFFERINGS
  • 25.24 SINGAPORE POST
    • 25.24.1 BUSINESS OVERVIEW
    • 25.24.2 SERVICE OFFERINGS
  • 25.25 SINOTRANS
    • 25.25.1 BUSINESS OVERVIEW
    • 25.25.2 SERVICE OFFERINGS
  • 25.26 XPO LOGISTICS
    • 25.26.1 BUSINESS OVERVIEW
    • 25.26.2 SERVICE OFFERINGS
  • 25.27 YOURWAY
    • 25.27.1 BUSINESS OVERVIEW
    • 25.27.2 SERVICE OFFERINGS
  • 25.28 YUSEN LOGISTICS
    • 25.28.1 BUSINESS OVERVIEW
    • 25.28.2 SERVICE OFFERINGS

26 REPORT SUMMARY

  • 26.1 KEY TAKEAWAYS
  • 26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

  • 27.1 MARKET BY GEOGRAPHY
  • 27.2 MARKET BY THERAPY AREA
  • 27.3 MARKET BY ORIGIN
  • 27.4 MARKET BY PRODUCT
  • 27.5 MARKET BY FUNCTION
  • 27.6 NORTH AMERICA BY THERAPY AREA
  • 27.7 NORTH AMERICA BY ORIGIN
  • 27.8 NORTH AMERICA BY PRODUCT
  • 27.9 NORTH AMERICA BY FUNCTION
  • 27.10 EUROPE BY THERAPY AREA
  • 27.11 EUROPE BY ORIGIN
  • 27.12 EUROPE BY PRODUCT
  • 27.13 EUROPE BY FUNCTION
  • 27.14 APAC BY THERAPY AREA
  • 27.15 APAC BY ORIGIN
  • 27.16 APAC BY PRODUCT
  • 27.17 APAC BY FUNCTION
  • 27.18 LATIN AMERICA BY THERAPY AREA
  • 27.19 LATIN AMERICA BY ORIGIN
  • 27.20 LATIN AMERICA BY PRODUCT
  • 27.21 LATIN AMERICA BY FUNCTION
  • 27.22 MIDDLE EAST & AFRICA AMERICA BY THERAPY AREA
  • 27.23 MIDDLE EAST & AFRICA BY ORIGIN
  • 27.24 MIDDLE EAST & AFRICA BY PRODUCT
  • 27.25 MIDDLE EAST & AFRICA BY FUNCTION

28 APPENDIX

  • 28.1 ABBREVIATIONS

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL PHARMACEUTICAL LOGISTICS MARKET
  • EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 GLOBAL PHARMACEUTICAL INDUSTRY 2003-2020 ($ TRILLIONS)
  • EXHIBIT 4 DSCSA IMPLEMENTATION TIMELINE
  • EXHIBIT 5 SUPPLY CHAIN ANALYSIS DURING COVID-19 PANDEMIC
  • EXHIBIT 6 ESTIMATED GROWTH OF ORIGIN SEGMENTATION BETWEEN 2021 AND 2027
  • EXHIBIT 7 GLOBAL PHARMACEUTICAL LOGISTICS MARKET REVENUE BY REGION, 2021
  • EXHIBIT 8 IMPACT OF GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS
  • EXHIBIT 9 NUMBER OF CLINICAL TRIALS PER YEAR, BY INCOME GROUP, 2015-2019
  • EXHIBIT 10 IMPACT OF DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS
  • EXHIBIT 11 TOP FOUR TECHNOLOGY TRENDS THAT CAN DISRUPT GLOBAL LOGISTICS LANDSCAPE
  • EXHIBIT 12 IMPACT OF INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS
  • EXHIBIT 13 M&A ACTIVITY IN THE CGT INDUSTRY (DEAL VALUE: $ BILLION), 2019
  • EXHIBIT 14 TOTAL GLOBAL REGENERATIVE MEDICINE FINANCING ($ BILLION)
  • EXHIBIT 15 CELL AND GENE THERAPY: LANDSCAPE AS OF 2021 AND FUTURE POTENTIAL
  • EXHIBIT 16 IMPACT OF INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES
  • EXHIBIT 17 GLOBAL BIOPHARMACEUTICAL COLD CHAIN SPENDING ($ BILLION)
  • EXHIBIT 18 IMPACT OF GROWING DEMAND FOR OCEAN FREIGHT SERVICE
  • EXHIBIT 19 IMPACT OF INCREASING DEMAND FOR GENERICS AND BIOSIMILARS
  • EXHIBIT 20 LEADING COUNTRIES IN GENERICS MARKET (AS OF 2019)
  • EXHIBIT 21 AGGREGATE VALUE OF GLOBAL PHARMACEUTICAL INDUSTRY 2014-2021 ($ TRILLIONS)
  • EXHIBIT 22 IMPACT OF LACK OF COMPLIANCE AND CHANGING REGULATIONS
  • EXHIBIT 23 COSTS INCURRED DUE TO TEMPERATURE DEVIATIONS, 2019 ($ BILLION)
  • EXHIBIT 24 IMPACT OF COVID-19 PANDEMIC
  • EXHIBIT 25 PERCENTAGE OF MANUFACTURERS REPORTED SUPPLY CHAIN INTERRUPTIONS AND DIFFICULTIES, 2020
  • EXHIBIT 26 IMPACT OF GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS
  • EXHIBIT 27 GLOBAL PHARMACEUTICAL LOGISTICS MARKET 2021-2027 ($ BILLION)
  • EXHIBIT 28 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021 & 2027 (%)
  • EXHIBIT 29 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021 & 2027 (%)
  • EXHIBIT 30 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021 & 2027 (%)
  • EXHIBIT 31 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021 & 2027 (%)
  • EXHIBIT 32 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY 2021 & 2027 (%)
  • EXHIBIT 33 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 34 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
  • EXHIBIT 35 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA
  • EXHIBIT 36 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA: IMPACT FACTOR
  • EXHIBIT 37 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA: INCREMENTAL GROWTH ($ BILLION)
  • EXHIBIT 38 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA: ABSOLUTE GROWTH (%)
  • EXHIBIT 39 TOTAL CONFIRMED MONKEYPOX CASES AS OF NOVEMBER 7, 2022
  • EXHIBIT 40 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY COMMUNICABLE DISEASES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 41 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY COMMUNICABLE DISEASES 2021-2027 ($ BILLION)
  • EXHIBIT 42 COMMUNICABLE DISEASES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 43 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ONCOLOGY: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 44 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ONCOLOGY 2021-2027 ($ BILLION)
  • EXHIBIT 45 ONCOLOGY: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 46 MOST COMMON MEDICATIONS FOR TYPE 2 DIABETES
  • EXHIBIT 47 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY DIABETES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 48 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY DIABETES 2021-2027 ($ BILLION)
  • EXHIBIT 49 DIABETES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 50 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY CVD: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 51 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY CARDIOVASCULAR DISEASES 2021-2027 ($ BILLION)
  • EXHIBIT 52 CARDIOVASCULAR DISEASES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 53 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY AUTOIMMUNE DISEASES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 54 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY AUTOIMMUNE DISEASES 2021-2027 ($ BILLION)
  • EXHIBIT 55 AUTOIMMUNE DISEASES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 56 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY NEUROLOGICAL DISORDERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 57 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY NEUROLOGICAL DISORDERS 2021-2027 ($ BILLION)
  • EXHIBIT 58 NEUROLOGICAL DISORDERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 59 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PAIN MANAGEMENT: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 60 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PAIN MANAGEMENT 2021-2027 ($ BILLION)
  • EXHIBIT 61 PAIN MANAGEMENT: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 62 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY RESPIRATORY DISEASES: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 63 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY RESPIRATORY DISEASES 2021-2027 ($ BILLION)
  • EXHIBIT 64 RESPIRATORY DISEASES: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 65 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 66 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS 2021-2027 ($ BILLION)
  • EXHIBIT 67 OTHERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 68 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
  • EXHIBIT 69 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN
  • EXHIBIT 70 TOTAL SPENDING ON BRANDED AND GENERIC DRUGS, US (%SHARE)
  • EXHIBIT 71 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN: INCREMENTAL GROWTH ($ BILLION)
  • EXHIBIT 72 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN: ABSOLUTE GROWTH (%)
  • EXHIBIT 73 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN: IMPACT FACTOR
  • EXHIBIT 74 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY BRANDED DRUGS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 75 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY BRANDED DRUGS 2021-2027 ($ BILLION)
  • EXHIBIT 76 BRANDED DRUGS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 77 ESTIMATED SAVINGS FROM GENERIC DRUG APPROVALS ($ BILLION)
  • EXHIBIT 78 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GENERIC DRUGS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 79 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GENERIC DRUGS 2021-2027 ($ BILLION)
  • EXHIBIT 80 GENERIC DRUGS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 81 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTC: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 82 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTC 2021-2027 ($ BILLION)
  • EXHIBIT 83 OTC: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 84 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 85 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT
  • EXHIBIT 86 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT: IMPACT FACTOR
  • EXHIBIT 87 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT: INCREMENTAL GROWTH ($ BILLION)
  • EXHIBIT 88 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT: ABSOLUTE GROWTH (%)
  • EXHIBIT 89 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY SMALL MOLECULE DRUGS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 90 NUMBER OF SMALL MOLECULE DRUGS APPROVED AS NMES BY FDA, 2017-2021
  • EXHIBIT 91 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY SMALL MOLECULE DRUGS 2021-2027 ($ BILLION)
  • EXHIBIT 92 SMALL MOLECULE DRUGS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 93 NUMBER OF BIOLOGICS APPROVED AS NMES BY FDA, 2017-2021
  • EXHIBIT 94 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY BIOLOGICS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 95 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY BIOLOGICS 2021-2027 ($ BILLION)
  • EXHIBIT 96 BIOLOGICS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 97 TOP MABS SALES BY GLOBAL SALES, 2019 ($ BILLION)
  • EXHIBIT 98 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY MONOCLONAL ANTIBODIES 2021-2027 ($ BILLION)
  • EXHIBIT 99 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY VACCINES 2021-2027 ($ BILLION)
  • EXHIBIT 100 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS 2021-2027 ($ BILLION)
  • EXHIBIT 101 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
  • EXHIBIT 102 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION
  • EXHIBIT 103 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION: IMPACT FACTOR
  • EXHIBIT 104 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION: INCREMENTAL GROWTH ($ BILLION)
  • EXHIBIT 105 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION: ABSOLUTE GROWTH (%)
  • EXHIBIT 106 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY TRANSPORTATION: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 107 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY TRANSPORTATION 2021-2027 ($ BILLION)
  • EXHIBIT 108 TRANSPORTATION: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 109 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ROAD 2021-2027 ($ BILLION)
  • EXHIBIT 110 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY WATER 2021-2027 ($ BILLION)
  • EXHIBIT 111 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY AIR 2021-2027 ($ BILLION)
  • EXHIBIT 112 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY WAREHOUSING: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 113 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY WAREHOUSING 2021-2027 ($ BILLION)
  • EXHIBIT 114 WAREHOUSING: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 115 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 116 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY OTHERS 2021-2027 ($ BILLION)
  • EXHIBIT 117 OTHERS: INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 118 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 119 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY
  • EXHIBIT 120 GEOGRAPHICAL SEGMENTATION OF SALES OF NEW MEDICINES LAUNCHED, 2015-2020 (%)
  • EXHIBIT 121 PHARMACEUTICAL R&D EXPENDITURE- ANNUAL GROWTH RATE 2006-2020 (%)
  • EXHIBIT 122 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ BILLION)
  • EXHIBIT 123 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
  • EXHIBIT 124 PERCENTAGE OF API MANUFACTURING FACILITIES FOR ALL DRUGS BY COUNTRY OR REGION, AUGUST 2019
  • EXHIBIT 125 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 126 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
  • EXHIBIT 127 PHARMACEUTICAL LOGISTICS MARKET IN NORTH AMERICA 2021-2027 ($ BILLION)
  • EXHIBIT 128 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
  • EXHIBIT 129 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
  • EXHIBIT 130 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 131 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
  • EXHIBIT 132 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 133 US PHARMACEUTICAL SALES FROM 2017-2021 ($ BILLION)
  • EXHIBIT 134 PHARMACEUTICAL LOGISTICS MARKET IN US 2021-2027 ($ BILLION)
  • EXHIBIT 135 IMPORTS AND EXPORTS OF PHARMACEUTICAL AND MEDICINAL PRODUCTS, NOVEMBER 2019-NOVEMBER 2021 ($ MILLION)
  • EXHIBIT 136 PHARMACEUTICAL LOGISTICS MARKET IN CANADA 2021-2027 ($ BILLION)
  • EXHIBIT 137 EUROPEAN PHARMACEUTICAL MANUFACTURING VALUE, 2019 ($ MILLION)
  • EXHIBIT 138 EUROPE PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 139 EUROPE PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
  • EXHIBIT 140 PHARMACEUTICAL LOGISTICS MARKET IN EUROPE 2021-2027 ($ BILLION)
  • EXHIBIT 141 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
  • EXHIBIT 142 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
  • EXHIBIT 143 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 144 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
  • EXHIBIT 145 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
  • EXHIBIT 146 TOTAL DRUG SALES IN GERMAN PHARMACY MARKET, 2019 (MILLION PACKAGING UNITS)
  • EXHIBIT 147 PHARMACEUTICAL PRODUCTION IN GERMANY, 2015-2018 ($ BILLION)
  • EXHIBIT 148 PRODUCT GROUPS EXPORTED BY AIR FREIGHT, 2017 ($ BILLION)
  • EXHIBIT 149 PHARMACEUTICAL LOGISTICS MARKET IN GERMANY 2021-2027 ($ BILLION)
  • EXHIBIT 150 SALES REVENUE OF OTC PHARMACEUTICALS, 2017-2021 ($ MILLION)
  • EXHIBIT 151 PHARMACEUTICAL LOGISTICS MARKET IN FRANCE 2021-2027 ($ BILLION)
  • EXHIBIT 152 GROWTH OF PHARMACEUTICAL WHOLESALE IN UK, 2016-2021
  • EXHIBIT 153 RECORDED DRUG CRIME IN ENGLAND AND WALES BETWEEN 2019-2020 AND 2020-2021
  • EXHIBIT 154 PHARMACEUTICAL LOGISTICS MARKET IN UK 2021-2027 ($ BILLION)
  • EXHIBIT 155 PHARMA INDUSTRY IN ITALY BY OWNERSHIP (% OF TOTAL)
  • EXHIBIT 156 EXPORT SALES OF PHARMACEUTICAL ITALIAN-OWNED COMPANIES (% OF OVERALL TURNOVER)
  • EXHIBIT 157 BIOSIMILAR CONSUMPTION IN 2018
  • EXHIBIT 158 PHARMACEUTICAL LOGISTICS MARKET IN ITALY 2021-2027 ($ BILLION)
  • EXHIBIT 159 OTC PHARMACEUTICALS TOTAL REVENUE, 2017-2021
  • EXHIBIT 160 PHARMACEUTICAL LOGISTICS MARKET IN SPAIN 2021-2027 ($ BILLION)
  • EXHIBIT 161 PHARMACEUTICAL SPENDING BY APAC COUNTRIES, 2018 ($ BILLION)
  • EXHIBIT 162 APAC PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 163 APAC PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
  • EXHIBIT 164 PHARMACEUTICAL LOGISTICS MARKET IN APAC 2021-2027 ($ BILLION)
  • EXHIBIT 165 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
  • EXHIBIT 166 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
  • EXHIBIT 167 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 168 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
  • EXHIBIT 169 INCREMENTAL GROWTH IN APAC 2021 & 2027
  • EXHIBIT 170 REVENUE SEGMENTATION OF PHARMACEUTICAL INDUSTRY IN CHINA, 2018 ($ BILLION)
  • EXHIBIT 171 TOTAL PHARMACEUTICAL COLD CHAIN LOGISTICS COST OF CHINA, 2018-2021
  • EXHIBIT 172 PHARMACEUTICAL LOGISTICS MARKET IN CHINA 2021-2027 ($ BILLION)
  • EXHIBIT 173 PHARMACEUTICAL LOGISTICS MARKET IN JAPAN 2021-2027 ($ BILLION)
  • EXHIBIT 174 BIOSIMILARS APPROVED BY COUNTRY AND REGION, 2019
  • EXHIBIT 175 INTERNATIONAL TRADE (EXPORT) IN PHARMACEUTICALS ($ BILLION)
  • EXHIBIT 176 INDIA'S DRUG AND PHARMACEUTICAL EXPORT TREND ($ BILLION)
  • EXHIBIT 177 MEDICINAL DRUG EXPORTS BY INDIA (2021-22)
  • EXHIBIT 178 PHARMACEUTICAL LOGISTICS MARKET IN INDIA 2021-2027 ($ BILLION)
  • EXHIBIT 179 DRUG EXPENDITURE DYNAMICS 1995-2020
  • EXHIBIT 180 PHARMACEUTICAL LOGISTICS MARKET IN SOUTH KOREA 2021-2027 ($ BILLION)
  • EXHIBIT 181 PHARMACEUTICAL LOGISTICS MARKET IN AUSTRALIA 2021-2027 ($ BILLION)
  • EXHIBIT 182 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 183 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
  • EXHIBIT 184 PHARMACEUTICAL LOGISTICS MARKET IN LATIN AMERICA 2021-2027 ($ BILLION)
  • EXHIBIT 185 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
  • EXHIBIT 186 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
  • EXHIBIT 187 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 188 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
  • EXHIBIT 189 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
  • EXHIBIT 190 PHARMACEUTICAL LOGISTICS MARKET IN BRAZIL 2021-2027 ($ BILLION)
  • EXHIBIT 191 PHARMACEUTICAL LOGISTICS MARKET IN MEXICO 2021-2027 ($ BILLION)
  • EXHIBIT 192 SALES OF PHARMACEUTICAL INDUSTRY 2017-2021 ($ BILLION)
  • EXHIBIT 193 OTC SALES 2017-2020 (%)
  • EXHIBIT 194 PHARMACEUTICAL EXPORTS AND IMPORTS 2017-2021 ($ BILLION)
  • EXHIBIT 195 PHARMACEUTICAL LOGISTICS MARKET IN ARGENTINA 2021-2027 ($ BILLION)
  • EXHIBIT 196 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
  • EXHIBIT 197 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET: KEY COUNTRIES 2021 ($ BILLION)
  • EXHIBIT 198 PHARMACEUTICAL LOGISTICS MARKET IN MIDDLE EAST & AFRICA 2021-2027 ($ BILLION)
  • EXHIBIT 199 INCREMENTAL GROWTH BY THERAPY AREA 2021 & 2027
  • EXHIBIT 200 INCREMENTAL GROWTH BY ORIGIN 2021 & 2027
  • EXHIBIT 201 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027
  • EXHIBIT 202 INCREMENTAL GROWTH BY FUNCTION 2021 & 2027
  • EXHIBIT 203 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 204 % SHARE OF BIOSIMILARS BY THERAPEUTIC AREAS, 2020 (%)
  • EXHIBIT 205 TURKEY PHARMACEUTICALS MARKET COMPOSITION, 2019 ($ BILLION)
  • EXHIBIT 206 TURKEY PHARMACEUTICALS MARKET COMPOSITION, 2019 ($ BILLION)
  • EXHIBIT 207 PHARMACEUTICAL LOGISTICS MARKET IN TURKEY 2021-2027 ($ BILLION)
  • EXHIBIT 208 SAUDI ARABIA PHARMACEUTICALS MARKET COMPOSITION, 2019 ($ BILLION)
  • EXHIBIT 209 PHARMACEUTICAL LOGISTICS MARKET IN SAUDI ARABIA 2021-2027 ($ BILLION)
  • EXHIBIT 210 PHARMACEUTICAL LOGISTICS MARKET IN SOUTH AFRICA 2021-2027 ($ BILLION)
  • EXHIBIT 211 GLOBAL PHARMACEUTICAL LOGISTICS MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
  • EXHIBIT 212 GLOBAL PHARMACEUTICAL LOGISTICS MARKET - MARKET DOMINANT ANALYSIS
  • EXHIBIT 213 AMERISOURCEBERGEN: TOTAL REVENUE, 2019-2021 ($ MILLION)
  • EXHIBIT 214 DB GROUP: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 215 DB GROUP: DG SCHENKER SUBSIDIARY REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 216 DB GROUP: NET CAPITAL EXPENDITURE, 2019-2021 ($ MILLION)
  • EXHIBIT 217 DEUTSCHE POST DHL GROUP: TOTAL REVENUE 2019-2021 ($ MILLION)
  • EXHIBIT 218 FEDEX REVENUE, 2019-2021
  • EXHIBIT 219 FEDEX CORPORATION: MAJOR SERVICE OFFERINGS

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS BETWEEN 2015 AND 2020
  • TABLE 4 COMMONLY PRESCRIBED MEDICATIONS ($ BILLION)
  • TABLE 5 POPULAR MEDICATIONS BY NUMBER OF MONTHLY PRESCRIPTIONS ANNUALLY (MILLIONS)
  • TABLE 6 TOP TEN BRANDED DRUGS SOLD BY RETAIL SALES, 2021 ($ BILLION)
  • TABLE 7 TOP SELLING OTC DRUGS AND REVENUE, ($ MILLION) 2018
  • TABLE 8 TOP 10 SMALL MOLECULE DRUGS BY SALES, 2021 ($ BILLION)
  • TABLE 9 TOP 10 EXPORTERS AND IMPORTERS OF HUMAN-USE VACCINES, 2020
  • TABLE 10 TOP SIX BEST-SELLING VACCINES, 2021 ($ BILLION)
  • TABLE 11 SALES OF PATENTED AND NON-PATENTED DRUGS BY CANADIAN MANUFACTURERS, 2011-2019 ($ BILLION)
  • TABLE 12 HEALTH EXPENDITURE OF CANADIANS, 2011-2019 ($ BILLION)
  • TABLE 13 TOTAL PHARMACEUTICALS MARKET ($ THOUSANDS), 2017-2020
  • TABLE 14 MEXICO PHARMACEUTICAL MARKET, 2018-2020 ($ BILLION)
  • TABLE 15 AMERISOURCEBERGEN: MAJOR SERVICE OFFERINGS
  • TABLE 16 CEVA LOGISTICS: MAJOR SERVICE OFFERINGS
  • TABLE 17 DB SCHENKER: MAJOR SERVICE OFFERINGS
  • TABLE 18 DEUTSCHE POST DHL GROUP: MAJOR SERVICE OFFERINGS
  • TABLE 19 KUEHNE + NAGEL: MAJOR SERVICE OFFERINGS
  • TABLE 20 UNITED PARCEL SERVICE: MAJOR SERVICE OFFERINGS
  • TABLE 21 ABS LOGISTICS: MAJOR SERVICE OFFERINGS
  • TABLE 22 AWL INDIA: MAJOR SERVICE OFFERINGS
  • TABLE 23 ALLOGA: MAJOR SERVICE OFFERINGS
  • TABLE 24 BOLLORE LOGISTICS: MAJOR SERVICE OFFERINGS
  • TABLE 25 CARDINAL HEALTH: MAJOR SERVICE OFFERINGS
  • TABLE 26 C.H. ROBINSON: MAJOR SERVICE OFFERINGS
  • TABLE 27 COLD CHAIN TECHNOLOGIES: MAJOR SERVICE OFFERINGS
  • TABLE 28 CRYOPDP: MAJOR SERVICE OFFERINGS
  • TABLE 29 DPD: MAJOR SERVICE OFFERINGS
  • TABLE 30 DSV: MAJOR SERVICE OFFERINGS
  • TABLE 31 FARMASOFT: MAJOR SERVICE OFFERINGS
  • TABLE 32 JEENA & COMPANY: MAJOR SERVICE OFFERINGS
  • TABLE 33 LUFTHANSA CARGO: MAJOR SERVICE OFFERINGS
  • TABLE 34 A.P. MOLLER - MAERSK: MAJOR SERVICE OFFERINGS
  • TABLE 35 MEDLINE: MAJOR SERVICE OFFERINGS
  • TABLE 36 NIPPON EXPRESS: MAJOR SERVICE OFFERINGS
  • TABLE 37 NOATUM LOGISTICS: MAJOR SERVICE OFFERINGS
  • TABLE 38 OWENS & MINOR: MAJOR SERVICE OFFERINGS
  • TABLE 39 OXIMIO: MAJOR SERVICE OFFERINGS
  • TABLE 40 PHARMA LOGISTICS: MAJOR SERVICE OFFERINGS
  • TABLE 41 PHOENIX GROUP: MAJOR SERVICE OFFERINGS
  • TABLE 42 PAREXEL INTERNATIONAL: MAJOR SERVICE OFFERINGS
  • TABLE 43 SEKO LOGISTICS: MAJOR SERVICE OFFERINGS
  • TABLE 44 SINGAPORE POST: MAJOR SERVICE OFFERINGS
  • TABLE 45 SINOTRANS: MAJOR SERVICE OFFERINGS
  • TABLE 46 XPO LOGISTICS: MAJOR SERVICE OFFERINGS
  • TABLE 47 YOURWAY: MAJOR SERVICE OFFERINGS
  • TABLE 48 YUSEN LOGISTICS: MAJOR SERVICE OFFERINGS
  • TABLE 49 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY 2021-2027 ($ BILLION)
  • TABLE 50 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 51 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 ($ BILLION)
  • TABLE 52 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 (%)
  • TABLE 53 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 ($ BILLION)
  • TABLE 54 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 (%)
  • TABLE 55 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 56 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 57 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 ($ BILLION)
  • TABLE 58 GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 (%)
  • TABLE 59 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 ($ BILLION)
  • TABLE 60 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 (%)
  • TABLE 61 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 ($ BILLION)
  • TABLE 62 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 (%)
  • TABLE 63 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 64 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 65 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 ($ BILLION)
  • TABLE 66 NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 (%)
  • TABLE 67 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 ($ BILLION)
  • TABLE 68 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 (%)
  • TABLE 69 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 ($ BILLION)
  • TABLE 70 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 (%)
  • TABLE 71 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 72 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 73 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 ($ BILLION)
  • TABLE 74 EUROPE PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 (%)
  • TABLE 75 APAC PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 ($ BILLION)
  • TABLE 76 APAC PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 (%)
  • TABLE 77 APAC PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 ($ BILLION)
  • TABLE 78 APAC PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 (%)
  • TABLE 79 APAC PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 80 APAC PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 81 APAC PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 ($ BILLION)
  • TABLE 82 APAC PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 (%)
  • TABLE 83 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 ($ BILLION)
  • TABLE 84 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 (%)
  • TABLE 85 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 ($ BILLION)
  • TABLE 86 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 (%)
  • TABLE 87 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 88 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 89 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 ($ BILLION)
  • TABLE 90 LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 (%)
  • TABLE 91 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 ($ BILLION)
  • TABLE 92 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA 2021-2027 (%)
  • TABLE 93 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 ($ BILLION)
  • TABLE 94 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN 2021-2027 (%)
  • TABLE 95 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 ($ BILLION)
  • TABLE 96 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT 2021-2027 (%)
  • TABLE 97 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 ($ BILLION)
  • TABLE 98 MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET BY FUNCTION 2021-2027 (%)